• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

东亚地区的骨质疏松症:评估与管理中的当前问题

Osteoporosis in East Asia: Current issues in assessment and management.

作者信息

Cheung Elaine Y N, Tan Kathryn C B, Cheung Ching-Lung, Kung Annie W C

机构信息

Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, China.

Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

出版信息

Osteoporos Sarcopenia. 2016 Sep;2(3):118-133. doi: 10.1016/j.afos.2016.07.001. Epub 2016 Jul 30.

DOI:10.1016/j.afos.2016.07.001
PMID:30775478
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6372753/
Abstract

The greatest burden of hip fractures around the world is expected to occur in East Asia, especially China. However, there is a relative paucity of information on the epidemiology and burden of fractures in East Asia. Osteoporosis is greatly under-diagnosed and under-treated, even among the highest-risk subjects who have already suffered fractures. The accessibility to bone densitometry, the awareness of the disease by professionals and the public, and the use and reimbursement of drugs are some of the areas which need improvement especially. Cost-effective analysis on screening strategy and intervention thresholds based on local epidemiology data and economic status are available only in Japan. In addition, clinical risk factor models for the assessment of fracture probability may be ethnic specific. Further research is needed to develop a cost-effective risk assessment strategy to identify high-risk individuals for screening and treatment based on local data. Moreover, inadequate calcium and vitamin D intake is still an issue faced by this region.

摘要

预计全球髋部骨折的最大负担将出现在东亚地区,尤其是中国。然而,关于东亚地区骨折的流行病学和负担的信息相对较少。骨质疏松症的诊断和治疗严重不足,即使在已经发生骨折的高危人群中也是如此。骨密度测定的可及性、专业人员和公众对该疾病的认识以及药物的使用和报销等方面尤其需要改进。目前只有日本有基于当地流行病学数据和经济状况的筛查策略和干预阈值的成本效益分析。此外,用于评估骨折概率的临床风险因素模型可能因种族而异。需要进一步开展研究,以制定一种具有成本效益的风险评估策略,根据当地数据识别需要筛查和治疗的高危个体。此外,钙和维生素D摄入不足仍是该地区面临的一个问题。

相似文献

1
Osteoporosis in East Asia: Current issues in assessment and management.东亚地区的骨质疏松症:评估与管理中的当前问题
Osteoporos Sarcopenia. 2016 Sep;2(3):118-133. doi: 10.1016/j.afos.2016.07.001. Epub 2016 Jul 30.
2
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.安大略省双能X线吸收法骨密度测定的应用:基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.美国医疗保健研究与质量局(AHRQ)对低骨密度或骨质疏松症男性和女性预防骨折治疗的比较效果评价总结:2007年报告更新版
J Manag Care Pharm. 2012 May;18(4 Suppl B):S1-15; discussion S13. doi: 10.18553/jmcp.2012.18.s4-b.1.
5
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.采用FRAX工具进行骨质疏松症管理的病例发现——英国的评估与干预阈值
Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Economic burden of osteoporosis-related hip fracture in Asia: a systematic review.亚洲骨质疏松性髋部骨折的经济负担:系统评价。
Osteoporos Int. 2017 Jul;28(7):2035-2044. doi: 10.1007/s00198-017-3985-4. Epub 2017 Mar 17.
8
Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.骨质疏松症临床指南。南非医学协会——骨质疏松症工作组。
S Afr Med J. 2000 Sep;90(9 Pt 2):907-44.
9
Fracture liaison services for osteoporosis in the Asia-Pacific region: current unmet needs and systematic literature review.亚太地区骨质疏松性骨折联络服务:当前未满足的需求和系统文献回顾。
Osteoporos Int. 2018 Apr;29(4):779-792. doi: 10.1007/s00198-017-4347-y. Epub 2017 Dec 28.
10
Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.预测中国绝经后妇女开始骨质疏松治疗的干预阈值:基于真实世界数据的成本效益分析。
Osteoporos Int. 2020 Feb;31(2):307-316. doi: 10.1007/s00198-019-05173-6. Epub 2019 Nov 21.

引用本文的文献

1
Prevalence of Osteoporosis in Patients with Distal Radius Fracture from Low-energy Trauma: An Observational Study.低能量创伤所致桡骨远端骨折患者骨质疏松症的患病率:一项观察性研究
JNMA J Nepal Med Assoc. 2025 Feb;63(282):93-97. doi: 10.31729/jnma.8884. Epub 2025 Feb 28.
2
Health outcomes and care needs after osteoporotic fractures in rural Chinese older adults: policy implications.中国农村老年人骨质疏松性骨折后的健康结局与护理需求:政策启示
Front Public Health. 2025 Jun 25;13:1601892. doi: 10.3389/fpubh.2025.1601892. eCollection 2025.
3
Global burden and trends of musculoskeletal disorders in postmenopausal elderly women: a 1990-2021 analysis with projections to 2045.绝经后老年女性肌肉骨骼疾病的全球负担及趋势:1990 - 2021年分析及至2045年的预测
Arthritis Res Ther. 2025 Jun 19;27(1):127. doi: 10.1186/s13075-025-03587-8.
4
Synthetic Data-Enhanced Classification of Prevalent Osteoporotic Fractures Using Dual-Energy X-Ray Absorptiometry-Based Geometric and Material Parameters.基于双能X线吸收法的几何和材料参数的合成数据增强型常见骨质疏松性骨折分类
Endocrinol Metab (Seoul). 2025 Jun;40(3):484-497. doi: 10.3803/EnM.2024.2211. Epub 2025 May 14.
5
Assessing bone and muscle health and their association in a Mongolian population aged 40 and older: a pioneering observational study.评估40岁及以上蒙古族人群的骨骼和肌肉健康及其关联:一项开创性的观察性研究。
Arch Osteoporos. 2025 May 6;20(1):58. doi: 10.1007/s11657-025-01548-x.
6
Prevalence of osteoporosis and associated factors among people aged 50 years and older in the Madhesh province of Nepal: a community-based cross-sectional study.尼泊尔马德西省 50 岁及以上人群骨质疏松症的患病率及相关因素:一项基于社区的横断面研究。
J Health Popul Nutr. 2024 Jul 4;43(1):100. doi: 10.1186/s41043-024-00591-7.
7
Prevalence of osteoporosis, sarcopenia, and high falls risk in healthy community-dwelling Thai older adults: a nationwide cross-sectional study.泰国健康社区居住老年人骨质疏松症、肌肉减少症及高跌倒风险的患病率:一项全国性横断面研究。
JBMR Plus. 2024 Jan 4;8(2):ziad020. doi: 10.1093/jbmrpl/ziad020. eCollection 2024 Feb.
8
Efficacy and Safety of Generic Alendronate for Osteoporosis Treatment.骨质疏松症治疗中通用阿仑膦酸钠的疗效与安全性
Orthop Res Rev. 2024 Feb 22;16:85-91. doi: 10.2147/ORR.S445202. eCollection 2024.
9
Fracture risk prediction in old Chinese people-a narrative review.中国老年人骨折风险预测:叙述性综述。
Arch Osteoporos. 2023 Dec 18;19(1):3. doi: 10.1007/s11657-023-01360-5.
10
Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.建立和验证深度学习作为女性骨密度检查工具的预测模型的可靠性。
Osteoporos Int. 2024 Jan;35(1):129-141. doi: 10.1007/s00198-023-06913-5. Epub 2023 Sep 20.

本文引用的文献

1
Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa.骨骼与心血管健康的营养策略:强健骨骼,软化动脉,而非相反。
Open Heart. 2016 Mar 22;3(1):e000325. doi: 10.1136/openhrt-2015-000325. eCollection 2016.
2
Cochrane Review Brief: Chinese Herbal Medicines for Treating Osteoporosis.Cochrane系统评价简报:用于治疗骨质疏松症的中草药
Online J Issues Nurs. 2015 Apr 1;20(2):11.
3
Calcium intake and risk of fracture: systematic review.钙摄入量与骨折风险:系统评价
BMJ. 2015 Sep 29;351:h4580. doi: 10.1136/bmj.h4580.
4
Epidemiology and management of osteoporosis in the People's Republic of China: current perspectives.中华人民共和国骨质疏松症的流行病学与管理:当前观点
Clin Interv Aging. 2015 Jun 25;10:1017-33. doi: 10.2147/CIA.S54613. eCollection 2015.
5
The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation.《2013年印度骨质疏松症的亚太地区审计、流行病学、成本及负担:国际骨质疏松症基金会报告》
Indian J Endocrinol Metab. 2014 Jul;18(4):449-54. doi: 10.4103/2230-8210.137485.
6
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.维生素D及维生素D类似物用于预防绝经后女性和老年男性骨折
Cochrane Database Syst Rev. 2014 Apr 14;2014(4):CD000227. doi: 10.1002/14651858.CD000227.pub4.
7
National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea.韩国骨质疏松症和骨折治疗的国家医疗保健预算影响分析。
J Bone Metab. 2013 May;20(1):17-23. doi: 10.11005/jbm.2013.20.1.17. Epub 2013 May 13.
8
A secular increase in BMD in Chinese women.中国女性骨密度的长期增长。
J Bone Miner Metab. 2014 Jan;32(1):48-55. doi: 10.1007/s00774-013-0463-8. Epub 2013 Apr 30.
9
The Osteoporosis Society of Hong Kong (OSHK): 2013 OSHK guideline for clinical management of postmenopausal osteoporosis in Hong Kong.香港骨质疏松症学会(OSHK):2013年香港绝经后骨质疏松症临床管理OSHK指南。
Hong Kong Med J. 2013 Apr;19 Suppl 2:1-40.
10
A review of minodronic acid hydrate for the treatment of osteoporosis.米诺膦酸水合物治疗骨质疏松症的综述。
Clin Interv Aging. 2013;8:185-9. doi: 10.2147/CIA.S23927. Epub 2013 Feb 15.